BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 9893189)

  • 1. Effect of intranasal fluticasone on cellular infiltration, endothelial adhesion molecule expression, and proinflammatory cytokine mRNA in nasal polyp disease.
    Hamilos DL; Thawley SE; Kramper MA; Kamil A; Hamid QA
    J Allergy Clin Immunol; 1999 Jan; 103(1 Pt 1):79-87. PubMed ID: 9893189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-11 and IL-17 expression in nasal polyps: relationship to collagen deposition and suppression by intranasal fluticasone propionate.
    Molet SM; Hamid QA; Hamilos DL
    Laryngoscope; 2003 Oct; 113(10):1803-12. PubMed ID: 14520110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GRbeta expression in nasal polyp inflammatory cells and its relationship to the anti-inflammatory effects of intranasal fluticasone.
    Hamilos DL; Leung DY; Muro S; Kahn AM; Hamilos SS; Thawley SE; Hamid QA
    J Allergy Clin Immunol; 2001 Jul; 108(1):59-68. PubMed ID: 11447383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluticasone propionate downregulates nasal fibroblast functions involved in airway inflammation and remodeling.
    Silvestri M; Sabatini F; Scarso L; Cordone A; Dasic G; Rossi GA
    Int Arch Allergy Immunol; 2002 May; 128(1):51-8. PubMed ID: 12037401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eosinophil infiltration in nonallergic chronic hyperplastic sinusitis with nasal polyposis (CHS/NP) is associated with endothelial VCAM-1 upregulation and expression of TNF-alpha.
    Hamilos DL; Leung DY; Wood R; Bean DK; Song YL; Schotman E; Hamid Q
    Am J Respir Cell Mol Biol; 1996 Oct; 15(4):443-50. PubMed ID: 8879177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Once daily intranasal fluticasone propionate (200 micrograms) reduces nasal symptoms and inflammation but also attenuates the increase in bronchial responsiveness during the pollen season in allergic rhinitis.
    Foresi A; Pelucchi A; Gherson G; Mastropasqua B; Chiapparino A; Testi R
    J Allergy Clin Immunol; 1996 Aug; 98(2):274-82. PubMed ID: 8757203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intranasal steroids decrease eosinophils but not mucin expression in nasal polyps.
    Burgel PR; Cardell LO; Ueki IF; Nadel JA
    Eur Respir J; 2004 Oct; 24(4):594-600. PubMed ID: 15459138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nasal eosinophilia and IL-5 mRNA expression in seasonal allergic rhinitis induced by natural allergen exposure: effect of topical corticosteroids.
    Masuyama K; Till SJ; Jacobson MR; Kamil A; Cameron L; Juliusson S; Lowhagen O; Kay AB; Hamid QA; Durham SR
    J Allergy Clin Immunol; 1998 Oct; 102(4 Pt 1):610-7. PubMed ID: 9802369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-related efficacy and tolerability of fluticasone propionate nasal drops 400 microg once daily and twice daily in the treatment of bilateral nasal polyposis: a placebo-controlled randomized study in adult patients.
    Penttilä M; Poulsen P; Hollingworth K; Holmström M
    Clin Exp Allergy; 2000 Jan; 30(1):94-102. PubMed ID: 10606936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preventive treatment of intranasal fluticasone propionate reduces cytokine mRNA expressing cells before and during a single nasal allergen provocation.
    Kleinjan A; Holm AF; Dijkstra MD; Boks SS; Severijnen L; Mulder PG; Fokkens WJ
    Clin Exp Allergy; 2000 Oct; 30(10):1476-85. PubMed ID: 10998026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NAVIGATE I: Randomized, Placebo-Controlled, Double-Blind Trial of the Exhalation Delivery System With Fluticasone for Chronic Rhinosinusitis With Nasal Polyps.
    Sindwani R; Han JK; Soteres DF; Messina JC; Carothers JL; Mahmoud RA; Djupesland PG
    Am J Rhinol Allergy; 2019 Jan; 33(1):69-82. PubMed ID: 30477309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eosinophil adhesion to nasal polyp endothelium is P-selectin-dependent.
    Symon FA; Walsh GM; Watson SR; Wardlaw AJ
    J Exp Med; 1994 Jul; 180(1):371-6. PubMed ID: 7516413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of different dosage schedules of inhaled fluticasone propionate on peripheral blood cytokine concentrations in childhood asthma.
    Visser MJ; Postma DS; Brand PL; Arends LR; Duiverman EJ; Kauffman HF
    Clin Exp Allergy; 2002 Oct; 32(10):1497-503. PubMed ID: 12372131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of fluticasone in severe polyposis.
    Lund VJ; Flood J; Sykes AP; Richards DH
    Arch Otolaryngol Head Neck Surg; 1998 May; 124(5):513-8. PubMed ID: 9604976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-13 mRNA and immunoreactivity in allergen-induced rhinitis: comparison with IL-4 expression and modulation by topical glucocorticoid therapy.
    Ghaffar O; Laberge S; Jacobson MR; Lowhagen O; Rak S; Durham SR; Hamid Q
    Am J Respir Cell Mol Biol; 1997 Jul; 17(1):17-24. PubMed ID: 9224205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intranasal beclomethasone reduces allergen-induced symptoms and superficial mucosal eosinophilia without affecting submucosal inflammation.
    Baroody FM; Rouadi P; Driscoll PV; Bochner BS; Naclerio RM
    Am J Respir Crit Care Med; 1998 Mar; 157(3 Pt 1):899-906. PubMed ID: 9517609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical budesonide treatment reduces endothelial expression of intercellular adhesion molecules (vascular cell adhesion molecule-1 and P-selectin) and eosinophil infiltration in nasal polyps.
    Tingsgaard PK; Bock T; Larsen PL; Tos M
    Acta Otolaryngol; 1999; 119(3):362-8. PubMed ID: 10380744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo expression of signal transducer and activator of transcription factor 6 (STAT6) in nasal mucosa from atopic allergic rhinitis: effect of topical corticosteroids.
    Ghaffar O; Christodoulopoulos P; Lamkhioued B; Wright E; Ihaku D; Nakamura Y; Frenkiel S; Hamid Q
    Clin Exp Allergy; 2000 Jan; 30(1):86-93. PubMed ID: 10606935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fluticasone propionate aqueous nasal spray for the treatment of chronic sinusitis with eosinophil].
    Ohta Y; Tsubaki K; Yamamoto M; Makino N; Ishikawa T; Ichimura K
    Nihon Jibiinkoka Gakkai Kaiho; 2006 Mar; 109(3):157-62. PubMed ID: 16615430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eosinophil markers in seasonal allergic rhinitis. Intranasal fluticasone propionate inhibits local and systemic increases during the pollen season.
    Nielsen LP; Bjerke T; Christensen MB; Skamling M; Peterson CG; Mygind N; Dahl R
    Allergy; 1998 Aug; 53(8):778-85. PubMed ID: 9722227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.